Drooling: Are botulinum toxin injections into the major salivary glands a good treatment option?

Journal of Child Neurology

Volumn 27, Issue 4, 2012, Pages 458-464

  Nordgarden, Hilde ^a   Østerhus, Ingvild ^a   Møystad, Anne ^b,c   Åsten, Pamela ^a   Johnsen, Ulf L H ^a   Storhaug, Kari ^a   Loven, Jens Øyvind ^a  

^a LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

adverse effects; botulinum toxin; disability; drooling; mouth

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BODY WEIGHT; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; DRUG EFFECT; DYSARTHRIA; DYSPHAGIA; ECHOGRAPHY; FEMALE; FOOD INTAKE; HUMAN; HYPERSALIVATION; MALE; PAROTID GLAND; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SALIVARY GLAND; SALIVATION; SCHOOL CHILD; SIDE EFFECT; SUBMANDIBULAR GLAND; TOOTH PLAQUE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADOLESCENT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROTOXINS; SALIVARY GLANDS; SALIVATION; SIALORRHEA; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 84859308581     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811419365     Document Type: Article

References (35)

1. Erasmus CE, Van HK, Rotteveel LJ, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol. 2009;51:454-459.
2. Senner JE, Logemann J, Zecker S, Gaebler-Spira D. Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol. 2004;46:801-806. (Pubitemid 39549653)
3. Jongerius PH, Van HK, Van Den Hoogen FJ, Rotteveel JJ. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr. 2005;41:351-353. (Pubitemid 41285831)
4. Franklin DL, Luther F, Curzon ME. The prevalence of malocclusion in children with cerebral palsy. Eur J Orthod. 1996;18:637-643. (Pubitemid 126444326)
5. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P. Saliva control issues in the neurologically challenged. A 30 year experience in team management. Int J Pediatr Otorhinolaryngol. 2006;70:519-527. (Pubitemid 43155198)
6. Sochaniwskyj AE, Koheil RM, Bablich K, Milner M, Kenny DJ. Oral motor functioning, frequency of swallowing and drooling in normal children and in children with cerebral palsy. Arch Phys Med Rehabil. 1986;67:866-874. (Pubitemid 17205295)
7. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol. 2000;42:674-680.
8. Oreland A, Heijbel J, Jagell S, Persson M. Oral function in the physically handicapped with or without severe mental retardation. ASDC J Dent Child. 1989;56:17-25.
9. Bothwell JE, Clarke K, Dooley JM, et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol. 2002;27:18-22. (Pubitemid 34826569)
10. Norderyd J, Nilsson K, Steinwall G, Graf J, Marcusson A. Oral use of atropine eye drops in children with excessive drooling [abstract]. International Association of Pediatric Dentistry; June 17-20, 2009; Munich.
11. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734-770.
12. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope. 2001;111:218-226. (Pubitemid 32142827)
13. Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112:566-571.
14. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301-304. (Pubitemid 28141617)
15. Laskawi R, Drobik C, Schonebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope. 1998;108:381-384. (Pubitemid 28136646)
16. Guntinas-Lichius O, Jungehulsing M. Treatment of chronic parotid sialectasis with botulinum toxin A. Laryngoscope. 2002;112:586-587. (Pubitemid 34225883)
17. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment-botulinum toxin A injections of the parotid glands. Med Hypotheses. 1997;48:337-339. (Pubitemid 27224159)
18. Friedman A, Potulska A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord. 2001;7:329-332.
19. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112:73-81. (Pubitemid 34037741)
20. Nobrega AC, Rodrigues B, Melo A. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients? Clin Neurol Neurosurg. 2009;111:430-432.
21. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg. 2003;61:454-457. (Pubitemid 36396973)
22. Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology. 2003;61:1279-1281. (Pubitemid 37377556)
23. Dogu O, Apaydin D, Sevim S, Talas DU, Aral M. Ultrasound-guided versus ''blind'' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg. 2004;106:93-96. (Pubitemid 38299270)
24. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004;83:304-311.
25. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, Van HK, Gabreels FJ. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr. 2001;160:509-512. (Pubitemid 32695833)
26. Jongerius PH, Van Den Hoogen FJ, Van LJ, Gabreels FJ, Van HK, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004;114:620-627. (Pubitemid 41529515)
27. Porta M, Gamba M, Bertacchi G, Vaj P. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry. 2001;70:538-540. (Pubitemid 32269697)
28. Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord. 2003;18:685-688. (Pubitemid 36790285)
29. Meijer JW, van Kuijk AA, Geurts AC, Schelhaas HJ, Zwarts MJ. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2008;87:321-324. (Pubitemid 351450754)
30. Winterholler MG, Erbguth FJ, Wolf S, Kat S. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry. 2001;70:417-418. (Pubitemid 32250917)
31. Erasmus CE, Van HK, Van Den Hoogen FJ, et al. Thickened saliva after effective management of drooling with botulinum toxin A. Dev Med Child Neurol. 2010;52:e114-e118.
32. Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. J Child Neurol. 2011;26:838-843.
33. Alrefai AH, Aburahma SK, Khader YS. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial. Clin Neurol Neurosurg. 2009;111:79-82.
34. Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope. 1991;101:960-964.
35. Reddihough D, Erasmus CE, Johnson H, McKellar GM, Jongerius PH. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement. Eur J Neurol. 2010;17(suppl 2):109-121.